Startups
Based on the science of Nucleosomics™, our unique Nu.Q™ technology measures nucleosomes circulating in the blood to identify the earliest signs of cancer and other diseases. Our mission is simple, we want to save lives, and by making disease screening as simple, low cost and as routine as cholesterol or pregnancy testing we believe we can help to detect disease sooner.
We’re excited to have launched our first product from our veterinary subsidiary, Volition Veterinary. The Nu.Q™ Vet Cancer Screening Test can currently detect canine lymphoma and hemangiosarcoma, which together make up a third of all cancers in dogs.
We are headquartered in Austin, Texas, with locations in Belgium, California, Singapore and the UK.
We’re excited to have launched our first product from our veterinary subsidiary, Volition Veterinary. The Nu.Q™ Vet Cancer Screening Test can currently detect canine lymphoma and hemangiosarcoma, which together make up a third of all cancers in dogs.
We are headquartered in Austin, Texas, with locations in Belgium, California, Singapore and the UK.
Overview
Location
United States, Texas, Austin
Employees
51-200
Founded date
2010
Mentions in press and media 32
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 30, 2026 | - | "We are in active discussions with several large diagnostic companies to accelerate the development of Nu.Q® NETs and believe the potential use cases represent a significant commercial opportunity with a Total Addressable Market on an ... |
| May 27, 2026 | - | First Quarter Revenue Growth: Reported $1M of revenue in the first quarter of 2026, representing a 300% increase year-over-year. Feline Lymphoma Manuscript Submission: Formally submitted the clinical manuscript for the Nu.Q® Vet cancer test... |
| Sep 20, 2024 | Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing | Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the p... |
| Sep 16, 2024 | Life Sciences Virtual Investor Forum Agenda Announced for September 19th | Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda f... |
| May 10, 2023 | VolitionRx Limited Announces First Quarter 2023 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Thursday, May 11, at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev., May 10, 2023 /PRNewswire/ -- VolitionRx Limited VNRX ("Volition") today announced financi... |
| Jan 8, 2023 | Volition Issues Business Review 2022 | HENDERSON, Nev, Jan. 8, 2023 /PRNewswire/ -- VolitionRx Limited VNRX ("Volition"), a multi-national epigenetics company, has issued a Business Review of 2022, outlining its key highlights as the organization transitions from a com... |
| May 31, 2022 | Volition Achieves CE Mark for Nu.Q® NETs Test | to aid the detection and evaluation of diseases associated with NETosis AUSTIN, Texas, May 31, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced that it... |
| May 12, 2022 | VolitionRx Limited Announces First Quarter 2022 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Thursday, May 12, at 8:30 a.m. U.S. Eastern Time AUSTIN, Texas, May 12, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today an... |
| May 6, 2022 | VolitionRx Limited Schedules First Quarter 2022 Earnings Conference Call and Business Update | Conference call to take place on Thursday May 12 at 08:30 a.m. Eastern Time Capital Markets Day Friday May 13 at 10:00 a.m. Eastern Time AUSTIN, Texas, May 6, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition&quo... |
Show more
Reviews 0
FAQ about VolitionRx
When was VolitionRx founded?
VolitionRx was founded in 2010.
What has the press written about VolitionRx?
Parsers VC has collected 32 articles mentioning VolitionRx, among them “Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing” (Sep 20, 2024) and “Life Sciences Virtual Investor Forum Agenda Announced for September 19th” (Sep 16, 2024).
Is VolitionRx still active?
Yes, VolitionRx is active; its latest activity on Parsers VC dates from Sep 17, 2026.